TMEM63A, associated with hypomyelinating leukodystrophies, is an evolutionarily conserved regulator of myelination

Julia Halford1, Amanda J Senatore1, Sage Berryman1

  • 1Vollum Institute, Oregon Health & Science University, Portland, OR 97239.

Insights

TMEM63A is crucial for oligodendrocyte myelination in the central nervous system (CNS). Mutations in TMEM63A cause infantile hypomyelinating leukodystrophy 19 (HLD19), offering new therapeutic targets.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Infantile hypomyelinating leukodystrophy 19 (HLD19) is a rare genetic disorder characterized by reduced central nervous system (CNS) myelin.
  • The gene TMEM63A, encoding a mechanosensitive ion channel, is implicated in HLD19, but its function in myelination is unknown.

Purpose of the Study:

  • To investigate the role of TMEM63A in oligodendrocyte (OL)-dependent myelination.
  • To explore the mechanism by which TMEM63A regulates myelination and its relevance to HLD19.

Main Methods:

  • Utilized mouse and zebrafish models with Tmem63a inactivation.
  • Generated OL-specific conditional mouse knockouts of Tmem63a.
  • Investigated TMEM63A localization and function in response to mechanical cues.
  • Analyzed patient-derived TMEM63A variants.

Main Results:

  • Tmem63a inactivation in mice and zebrafish led to myelination deficits, mimicking HLD19.
  • OL-specific knockouts showed transient myelin reductions, indicating cell-autonomous regulation by TMEM63A.
  • TMEM63A localizes to the plasma membrane and lysosomes, modulating myelin production under mechanical stimulation.
  • HLD19 variants impaired TMEM63A trafficking to the cell membrane.

Conclusions:

  • TMEM63A is a key regulator of CNS myelination, acting cell-autonomously in oligodendrocytes.
  • Dysfunctional TMEM63A, due to genetic variants, causes HLD19 by disrupting myelination.
  • This study provides insights into hypomyelinating leukodystrophies and potential therapeutic strategies.